Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial, Lancet, vol.382, pp.1705-1718, 2013. ,
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis, N Engl J Med, vol.373, pp.2534-2582, 2015. ,
Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet, vol.386, pp.1137-1183, 2015. ,
Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis, N Engl J Med, vol.373, pp.1329-1368, 2015. ,
Th17 cells expressing KIR3DL2+ and responsive to HLA-B27 homodimers are increased in ankylosing spondylitis, J Immunol, vol.186, pp.2672-80, 2011. ,
Combinatorial control of Th17 and Th1 cell functions by genetic variations in genes associated with the interleukin-23 signaling pathway in spondyloarthritis, Arthritis Rheum, vol.65, pp.1510-1531, 2013. ,
IL-17-producing CD4+ T cells are increased in early, active axial spondyloarthritis including patients without imaging abnormalities, Rheumatology (Oxford), vol.54, pp.728-763, 2015. ,
Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive ?/? T cells in patients with active ankylosing spondylitis, Arthritis Rheum, vol.64, pp.1420-1429, 2012. ,
Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression, Arthritis Rheumatol, vol.66, pp.1272-81, 2014. ,
Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response, Arthritis Res Ther, vol.13, p.95, 2011. ,
Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis, J Immunol, vol.187, pp.490-500, 2011. ,
Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis, Arthritis Rheum, vol.64, pp.99-109, 2012. ,
In vivo induction of cutaneous inflammation results in the accumulation of extracellular trapforming neutrophils expressing ROR?t and IL-17, J Invest Dermatol, vol.134, pp.1276-84, 2014. ,
IL-17A localizes in the exocytic compartment of mast cells in psoriatic skin, Br J Dermatol, vol.177, pp.1458-60, 2017. ,
IL-23 induces spondyloarthropathy by acting on ROR-?t+ CD3+CD4?CD8? entheseal resident T cells, Nat Med, vol.18, pp.1069-76, 2012. ,
The biology of innate lymphoid cells, Nature, vol.517, pp.293-301, 2015. ,
A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity, Nature, vol.457, pp.722-727, 2009. ,
ROR?t(+) innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44, Immunity, vol.38, pp.1223-1258, 2013. ,
ROR?t+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota, Nat Immunol, vol.12, pp.320-326, 2011. ,
Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis, Nat Immunol, vol.17, pp.765-74, 2016. ,
Functional differences between human NKp44(?) and NKp44(+) RORC(+) innate lymphoid cells, Front Immunol, vol.3, p.72, 2012. ,
Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells, Nat Immunol, vol.10, pp.66-74, 2009. ,
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis, Ann Rheum Dis, vol.74, pp.1739-1786, 2015. ,
Enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluid, Arthritis Rheumatol, vol.67, pp.2673-2681, 2015. ,
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease, J Exp Med, vol.208, pp.1127-1160, 2011. ,
Group 3 innate lymphoid cells in human enthesis, Arthritis Rheumatol, vol.69, pp.1816-1838, 2017. ,
Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis, Nat Commun, vol.8, p.1510, 2017. ,
The assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general, Ann Rheum Dis, vol.70, pp.25-31, 2011. ,
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis Rheum, vol.31, pp.315-339, 1988. ,
Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients, Clin Rheumatol, vol.18, pp.434-475, 1999. ,
Visualizing high-dimensional data using t-SNE, J Mach Learn Res, vol.9, pp.2579-605, 2008. ,
Human innate lymphoid cells, Blood, vol.124, pp.700-709, 2014. ,
Innate lymphoid cells: a proposal for uniform nomenclature, Nat Rev Immunol, vol.13, pp.145-154, 2013. ,
Interleukin-1 and IL-23 induce innate IL-17 production from ?? T cells, amplifying Th17 responses and autoimmunity, Immunity, vol.31, pp.321-351, 2009. ,
Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis, J Invest Dermatol, vol.134, pp.984-91, 2014. ,
Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients, J Invest Dermatol, vol.134, pp.2351-60, 2014. ,
Human mast cells capture, store, and release bioactive, exogenous IL-17A, J Leukoc Biol, vol.100, pp.453-62, 2016. ,